pull down to refresh

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four months, new research being presented at this year’s European Congress on Obesity (ECO 2025) has found.
Alcohol use disorder is a relapsing condition that accounts for 2.6 million deaths a year – 4.7% of all deaths globally.
Treatments such as cognitive behavioural therapy (CBT), therapies that aim to strengthen motivation to stop or reduce drinking and medication can be very successful in the short-term, however, 70% of patients relapse within the first year.
...
Fascinating!** It's surprising how a weight-loss drug can have such a positive impact on alcohol consumption. Who would have thought that fighting obesity could also help tackle alcoholism issues at the same time?
reply